Inferior mesenteric artery diameter and number of patent lumbar arteries as factors associated with significant type 2 endoleak after infrarenal endovascular aneurysm repair.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
15 06 2022
Historique:
received: 15 06 2021
revised: 10 01 2022
accepted: 27 01 2022
pubmed: 16 4 2022
medline: 7 7 2022
entrez: 15 4 2022
Statut: ppublish

Résumé

Our goal was to identify the inferior mesenteric artery diameter and number of patent lumbar arteries causing a significant type 2 endoleak to develop after infrarenal endovascular aneurysm repair. Included were patients who underwent infrarenal endovascular aneurysm repair between April 2002 and January 2017. Patients with an aneurysm involving the iliac arteries were excluded. Significant type 2 endoleak was defined as a type 2 endoleak observed after infrarenal endovascular aneurysm repair and accompanied by abdominal aneurysm growth of at least 5 mm during that time. A total of 277 patients were included. Mean follow-up was 38.9 (standard deviation 121.6) months. Immediately after infrarenal endovascular aneurysm repair, type 2 endoleaks occurred in 55 patients (20%), resolving spontaneously in 2 patients 6 months after infrarenal endovascular aneurysm repair. Thirty (10.8%) patients revealed a significant type 2 endoleak with aneurysm sack enlargement > 5 mm during follow-up, for which inferior mesenteric artery or lumbar artery coiling was performed. Mean time for coiling after primary infrarenal endovascular aneurysm repair was 25.4 (standard deviation 19.10) months. Twenty-three patients (8.3%) showed a non-significant type 2 endoleak during follow-up (no aneurysm sack enlargement). We found that the inferior mesenteric artery diameter and number of patent lumbar arteries were factors associated with a significant type 2 endoleak (odds ratio 1.755, P = 0.001; odds ratio 1.717, P < 0.001, respectively). Prior to endovascular aneurysm repair, the inferior mesenteric artery was patent in 212 (76.5%) patients; its median diameter measured 3 (0.5-3.8) mm. The median number of patent lumbar arteries was 3 (2-4). According to our receiver operating characteristic curve analysis, an inferior mesenteric artery diameter ≥3 mm (sensitivity 93.3%, specificity 65%) and ≥3 patent lumbar arteries (sensitivity 87.5%, specificity 43.6%) proved to be optimal cut-off values related to developing a significant type 2 endoleak. We therefore propose a composite score for the development of a significant type 2 endoleak [(inferior mesenteric artery diameter + patent lumbar arteries)/2]. Patients in whom the diameter of the inferior mesenteric artery is ≥ 3 mm and with ≥ 3 patent lumbar arteries carry a higher risk of developing significant type 2 endoleak after infrarenal endovascular aneurysm repair.

Identifiants

pubmed: 35425973
pii: 6568948
doi: 10.1093/icvts/ivac016
pmc: PMC9252125
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Références

ANZ J Surg. 2008 Jan-Feb;78(1-2):61-3
pubmed: 18199208
J Vasc Surg. 2001 Jun;33(6):1193-8
pubmed: 11389417
J Vasc Surg. 2015 Sep;62(3):551-61
pubmed: 26059094
Surg Today. 2016 Jan;46(1):48-55
pubmed: 25578204
J Vasc Interv Radiol. 2018 Aug;29(8):1167-1173
pubmed: 29941385
J Vasc Surg. 2000 Jan;31(1 Pt 1):134-46
pubmed: 10642716
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
Cardiovasc Diagn Ther. 2018 Apr;8(Suppl 1):S131-S137
pubmed: 29850425
Ann Vasc Surg. 2006 Jan;20(1):69-74
pubmed: 16378143
Circulation. 2015 Jan 13;131(2):211-9
pubmed: 25561516
J Endovasc Ther. 2011 Jun;18(3):299-305
pubmed: 21679064
J Vasc Surg. 2007 Jul;46(1):1-8
pubmed: 17543489
Ann Vasc Surg. 2014 Apr;28(3):554-9
pubmed: 24090829
J Vasc Surg. 2010 Jul;52(1):19-24
pubmed: 20478685
J Vasc Surg. 2013 May;57(5):1291-7
pubmed: 23465173
J Vasc Surg. 2019 Jun;69(6):1736-1746
pubmed: 30591300
J Vasc Surg. 2016 Jan;63(1):32-8
pubmed: 26432285
Eur J Vasc Endovasc Surg. 2015 Nov;50(5):671-4
pubmed: 26319477
Eur J Vasc Endovasc Surg. 2016 May;51(5):632-9
pubmed: 26860254
Br J Surg. 2013 Sep;100(10):1262-70
pubmed: 23939840
Semin Intervent Radiol. 2007 Mar;24(1):38-42
pubmed: 21326734
Cardiovasc Intervent Radiol. 2014 Apr;37(2):324-8
pubmed: 23703668
J Endovasc Ther. 2000 Aug;7(4):297-301
pubmed: 10958294
J Vasc Surg. 2019 Apr;69(4):1309-1313
pubmed: 30905367
Ann Vasc Surg. 2018 Apr;48:166-173
pubmed: 29275128
PLoS One. 2017 Feb 9;12(2):e0170600
pubmed: 28182753

Auteurs

Stoyan Kondov (S)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Aleksandar Dimov (A)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Friedhelm Beyersdorf (F)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Lars Maruschke (L)

Center of Diagnostic and interventional Radiology, St. Josefs Hospital, Freiburg, Germany.

Jan-Steffen Pooth (JS)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Maximilian Kreibich (M)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Klaus Kaier (K)

Center for Medical Biometry and Informatics, University Medical Center, Freiburg, Germany.

Matthias Siepe (M)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Martin Czerny (M)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Bartosz Rylski (B)

Department of Cardiovascular Surgery, Faculty of Medicine, University Heart Centre, University Hospital Freiburg, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH